Document is current
Any future updates will be listed below
-
Authors
Wolfram, Lasse https://orcid.org/0000-0003-1549-5889
Merle, David A. https://orcid.org/0000-0003-4485-5580
Kühlewein, Laura https://orcid.org/0000-0003-1906-8681
Reith, Milda https://orcid.org/0000-0003-3656-0707
Kempf, Melanie https://orcid.org/0000-0002-0370-0462
Stingl, Krunoslav https://orcid.org/0000-0001-8547-7593
Haack, Tobias https://orcid.org/0000-0001-6033-4836
Mazzola, Pascale https://orcid.org/0000-0002-2971-5603
Poths, Karin https://orcid.org/0009-0006-1402-5788
Weisschuh, Nicole https://orcid.org/0000-0002-1047-6227
Wissinger, Bernd https://orcid.org/0000-0001-8964-5953
Kohl, Susanne https://orcid.org/0000-0002-6438-6331
Stingl, Katarina https://orcid.org/0000-0002-8132-911X
-
Funding
Funding for this research was provided by:
Universitätsklinikum Tübingen
- License Information
-
More Information
Article History
Received: 21 January 2025
Accepted: 8 April 2025
First Online: 23 April 2025
Declarations
:
: This study involves human participants and was approved by the Ethics Committee of the University of Tübingen (367/2019BO1, 116/2015BO2, 637/2017BO1) and adhered to the principles of the Declaration of Helsinki. Written informed consent for genetic testing was obtained for all individuals. For probands who were minors at the time of blood collection, informed consent was obtained from the parents or legal guardians.
: All individuals (and their legal guardians, where applicable), whose personal data are included in this manuscript, gave written informed consent for their personal or clinical details along with any identifying images to be published in this study.
: KS has no financial conflicts of interest for this work. KS was/is consultant for Novartis, ProQR Therapeutics, ViGeneron, Santen, Janssen, Lundbeck, THEA, with all fees paid to the University Tübingen to support research. All other authors declare that they have no competing interests.
